Gastroenterology Clinics of North America 1998: Vol 27 Index

29 Pages·1998·4.7 MB·English

CUMULATIVE INDEX 1998
Volume 27
March PREGNANCY AND GASTROINTESTINAL DISORDERS, pages
1-288
June CLINICAL NUTRITION, pages 289-532
September GASTROINTESTINAL DISORDERS AND SYSTEMIC DISEASE,
PART I, pages 533-720
December GASTROINTESTINAL DISORDERS AND SYSTEMIC DISEASE,
PART II, pages 721-933
Note: Page numbers of article titles are in boldface type.
Abdominal pain, in diabetes mellitus, 871 in irritable bowel syndrome, 15-16
in familial Mediterranean fever, 764 in liver disease, 19-24
in Henoch-Sch6nlein purpura, 751-752 in pancreatitis, 16-17
in mesenteric vasculopathy, 838-839 in peptic ulcer disease, 12
arterial, 792-793 in placental disorders, 7
colonic, 830 in porphyria, 24
venous, 805-806, 836 in preeclampsia, 19-21
in polyarteritis nodosa, 749 in urinary tract disorders, 24-26
in pregnancy, 1-36 in uterine leiomyoma, 9-10
abdominal, 6 parietal, 2
aborted, 7 perception of, 1-2
ectopic, 2-6 preterm labor, 7-8
extra-abdominal causes of, 26-27 referred, 2
heterotopic, 7 visceral, 2
idiopathic, 27 in systemic lupus erythematosus, 753—
imaging of, 27-28 755
in acute fatty liver of pregnancy, 22- in Takayasu arteritis, 768
23, 174 Abdominal trauma, in pregnancy, 83-85
in adnexal pathology, 8-9 Abortion, in hyperemesis gravidarum,
in appendicitis, 10-11, 74-76 137-138
in biliary tract disease, 17-19, 77 spontaneous, pain in, 7
in Budd-Chiari syndrome, 23 Abruptio placentae, pain in, 7
in colorectal cancer, 227 Abscess, appendiceal, in pregnancy, 76-77
in eclampsia, 19-21 liver, in pregnancy, 24
in endometriosis, 9 Absorptiometry, dual-energy x-ray, in
in gastroesophageal reflux, 12 nutritional assessment, 364
in HELLP syndrome, 20-21 Acanthosis nigricans, 631
in hepatic hemorrhage with rupture, Achlorhydria, in elderly persons, 315-316,
21-22 320
in inflammatory bowel disease, 15 Acidosis, intestinal epithelial
in intestinal obstruction, 12-14, 80-82 hyperpermeability in, 293
in intestinal pseudo-obstruction, 14-15 lactic, in short bowel syndrome, 471
905
906 CUMULATIVE INDEX 1998
Acquired immunodeficiency syndrome. bone disease in, 516-517
See Human immunodeficiency virus Alginic acid, in gastroesophageal reflux
infection. disease, in pregnancy, 162
Acrochordons, 630 Alkaline phosphatase, measurement of, in
Acrodermatitis, papular, of childhood, in colorectal cancer, in pregnancy, 230
hepatitis B, 616 Allopurinol, in ulcer disease, 409
Acupressure, in nausea and vomiting of Alternative therapies, for inflammatory
pregnancy, 145-146 bowel disease, 446
Acute Physiology and Chronic Health Aluminum hydroxide antacids, in
Evaluation (APACHE) score, in gastroesophageal reflux disease, in
pancreatitis, 422 pregnancy, 162
Acute superior mesenteric vasculopathy, Amenorrhea, in Wilson’s disease, 669
783-825 American Cancer Society, dietary
anatomic considerations in, 784, 786-789 guidelines of, 338
arterial, 789-803 Amino acids, in enteral nutrition, 381-382
causes of, 789-792 metabolism of, in kidney failure, 878
clinical features of, 792-794 5-Aminosalicylic acid, in inflammatory
diagnosis of, 794-799 bowel disease, in pregnancy, 217-218
prognosis for, 803 Amitriptyline, in abdominal pain, in
treatment of, 799-803 diabetes mellitus, 871
Ammonia retention, in kidney failure, 878
venous, 803-814
Ampicillin, in endoscopy, in pregnancy, 42,
causes of, 804
45-46
clinical features of, 805-806
Amyloidosis, 595-614
diagnosis of, 809-811
clinical features of, 596-599
differential diagnosis of, 806-809
versus amyloid type, 601, 603, 605-606
epidemiology of, 804
diagnosis of, 599-600
prognosis for, 813-814
endoscopy in, 601
treatment of, 811-813 familial, 596, 608-610
Adenocarcinoma, biliary tract, in in dialysis, 596, 883, 886-887
pregnancy, 19 in familial Mediterranean fever, 764
esophageal, nutritional factors in, 327- in inflammatory bowel disease, 606-608
329 in kidney failure, 886-887
Adenomas, liver, in pregnancy, 23-24 in rheumatoid arthritis, 758
Adenomatous polyposis syndromes, of colon, 599
ophthalmologic disorders in, 706-707 of esophagus, 597
Adenopathy, in Whipple’s disease, 689-690 of kidney, 606-609
Adenoviruses, in celiac disease of liver, 599
pathogenesis, 454 of mouth, 596-597
Adhesions, intestinal obstruction in, in of pancreas, 599
pregnancy, 13 of small intestine, 598
Adnexal pathology, in pregnancy, pain in, of stomach, 597-598
8-9 of thyroid gland, 607
Adrenergic agents, in asthma, plasma cell dyscrasias in, 595
gastroesophageal reflux from, 729 primary, 595, 601
Aging. See Elderly persons. radiography of, 600-601
AIDS. See Human immunodeficiency virus secondary, 595
infection. senile, 596
Air embolism, in home parenteral treatment of, 610-611
nutrition, 499 types of, 595-596, 605
Airway resistance, in gastroesophageal Anemia, in colorectal cancer, in pregnancy,
reflux disease, 723-733 228, 230, 239
Albumin, serum, in nutritional assessment, in Whipple’s disease, 688
350-351 iron-deficiency, in inflammatory bowel
Alcohol ingestion, cancer in, antioxidants disease, 436
and, 412 pernicious, atrophic gastritis in, 316, 320
colorectal, 335 in diabetes mellitus, 867
esophageal, 328-329 Anesthesia, fetal effects of, 262
oral, 327 Aneurysms, splenic artery, in pregnancy,
liver diseases in, antioxidants in, 413 82
CUMULATIVE INDEX 1998 907
Angiodysplasia, in kidney failure, 886 in chemotherapy complications, 413
Angiography, in mesenteric vasculopathy, in inflammatory bowel disease, 409-410
796-798, 810-811, 841-842 in liver disease, 413-414
Angioid streaks, in pseudoxanthoma in pancreatitis, 407-409
elasticum, 708 in peptic ulcer disease, 409
Angiomas, spider, in liver disease, 620-621 in radiation therapy complications, 413
Angioplasty, in mesenteric vasculopathy, interactions among, 406-407
803, 843-844 Antiphospholipid antibody syndrome,
Ankylosing spondylitis, gastrointestinal gastrointestinal manifestations of,
manifestations of, 766-767 756-757
in inflammatory bowel disease, 540-541 in viral hepatitis, 547
Anorectal disorders, in diabetes mellitus, Antipsychotic drugs, in functional
871 gastrointestinal disorders, 900
in pregnancy, 264-265 Antireflux surgery, in asthma, 729-731
in scleroderma, 585-588 in scleroderma, 576-577
Anorexia, in mesenteric vasculopathy, 805
Antireticulin antibodies, in celiac disease,
in systemic lupus erythematosus, 753
458
Antacids, in gastroesophageal reflux
Anxiolytics, in functional gasirointestinal
disease, in pregnancy, 162
disorders, 900
in peptic ulcer disease, in pregnancy, 179
Aortography, in mesenteric vasculopathy,
side effects of, in diabetes mellitus, 862
842
Anthropometry, in nutritional assessment,
Aortomesenteric bypass, in mesenteric
349
Antibiotics, for catheter lock, in home vasculopathy, 844
parenteral nutrition, 492 APACHE (Acute Physiology and Chronic
in bacterial overgrowth syndrome, in Health Evaluation) score, in
scleroderma, 583 pancreatitis, 422
in pregnancy, in appendicitis, 77 Aphthous ulcers, in Behcet’s disease, 703
in biliary tract disease, 78 in inflammatory bowel disease, 633
in diarrhea, 207 Apnea, in gastroesophageal reflux disease,
in endoscopy, 42-43, 45-46 736-737
in inflammatory bowel disease, 7 o2f2 0 Appendicitis, in pregnancy, 10-11
in Whipple’s disease, 692, 702 surgery for, 74-77
Anticardiolipin antibodies, in viral versus mesenteric vasculopathy, 806
hepatitis, 547 Arm muscle circumference, in nutritional
Anticholinergics, in nausea and vomiting assessment, 349
of pregnancy, 141-142 Arrhythmias, cardiac, in hemochromatosis,
Anticoagulants, in mesenteric 645-646
vasculopathy, 812 in Wilson’s disease, 668-669
Antidepressants, in functional Arteriopathy, superior mesenteric. See
gastrointestinal disorders, 900 Acute superior mesenteric vasculopathy,
Antiemetics, in gastroparesis, in diabetes arterial.
mellitus, 866 Arteritis, gastrointestinal manifestations of,
in hyperemesis gravidarum, 112, 140- giant cell, 768-769
141 in systemic lupus erythematosus, 753
Antiendomysial antibodies, in celiac Takayasu, 767-768
disease, 458 Arthritis and arthralgia, bypass, 543
Antigliadin antibodies, in celiac disease, colitic, 766-767
458 in inflammatory bowel disease, 540
Antihistamines, in nausea and vomiting of in autoimmune hepatitis, 549
pregnancy, 141-142 in celiac disease, 543
Antineutrophilic cytoplasmic in cystic fibrosis, 553
autoantibodies, vasculitis in, in familial Mediterranean fever, 554, 608
gastrointestinal manifestations of, in hemochromatosis, 548-549, 639, 647-
750-751 648
Antioxidants, 403-419 in hepatitis, viral, 545-546, 616
cocktails of, 408 in occult malignancy, 554
endogenous, 404-407 in pancreatic disease, 553
in cancer and cancer prevention, 335, in primary biliary cirrhosis, 551
410-413 in Whipple’s disease, 686-687
908 CUMULATIVE INDEX 1998
Arthritis and arthralgia (Continued) in mesenteric vasculopathy, 799, 811, 831
in Wilson’s disease, 669 in scleroderma, of colon, 585
peripheral, in inflammatory bowel dis- of esophagus, 571
ease, 539-540 of small intestine, 578
psoriatic, gastrointestinal manifestations in Whipple’s disease, 691
of, 767 Barrett’s metaplasia and carcinoma, in
reactive, gastrointestinal manifestations scleroderma, 569-571, 573-574
of, 765-766 nutritional factors in, 328-329
in infections, 535-537 Barrier function, of intestine, enteral
septic, in colon carcinoma, 543-544 nutrition and, 371-372
Ascites, in systemic lupus erythematosus, failure of. See Intestinal epithelial
755 hyperpermeability.
pancreatic, nutrition in, 427-428 Basal energy expenditure, in pregnancy,
Ascorbic acid requirements, in pregnancy, 104
94 Basal ganglia, copper accumulation in, 667
Aspiration, of gastric contents, in enteral Behavioral therapy, for functional
nutrition, pneumonia in, 379-380 gastrointestinal disorders, 902
in scleroderma, 570 for gastroesophageal reflux, in sclero-
in tube feeding, 108 derma, 575
respiratory complications of. See Behcet's disease, gastrointestinal
Gastroesophageal reflux disease, manifestations of, 752-753
respiratory complications of. ophthalmologic disorders in, 702-704
Aspirin, liver disorders from, 771 Belsey Mark IV repair, in scleroderma,
Asthma, in gastroesophageal reflux 576-577
disease, 723-733 Bendectin, in nausea and vomiting of
Atherosclerosis, of mesenteric arteries, pregnancy, 143
chronic ischemia in, 837-839 Beta-carotene, in cancer prevention,
ischemic colitis in, 828-829 411-413
ATP depletion, intestinal epithelial colorectal, 335-337
hyperpermeability in, 292-294, 296 gastric, 331
ATP7B product, in Wilson’s disease, 659, Bile acid deconjugation test, in
662 scleroderma, 582
Atrophic gastritis, 315-316, 320 Bile salt metabolism, alterations of, in
in Sjégren’s syndrome, 760-761 Whipple’s disease, 688-689
Autoimmune hepatitis, rheumatic disease Biliary cirrhosis, primary, bone disease in,
in, 549-550 517-518
Autonomic dysfunction, in diabetes in scleroderma, 588
mellitus, esophageal abnormalities in, ophthalmologic disorders in, 706
862-863 rheumatic disease in, 550-551
Azathioprine, gastrointestinal effects of, Biliary tract, copper excretion in, in
774 Wilson’s disease, 659-661
in inflammatory bowel disease, in preg- disease of, in diabetes mellitus, 868
nancy, 219 in pregnancy, 17-19
AZT (zidovudine), in HIV infection, in endoscopic retrograde cholangiopan-
vertical transmission prevention, creatography in, 49, 54-59,
272-273 78-79
surgery in, 17-19, 77-79
in Sjégren’s syndrome, 761-762
obstruction of, antioxidants in, 414
Bacteremia, in home parenteral nutrition, Biofeedback, in functional gastrointestinal
491 disorders, 902
Bacterial overgrowth, in diabetes mellitus, Bioimpedance analysis, in nutritional
869-870 assessment, 363-364
in scleroderma, 579-580, 582-583 Biopsy, bone, in metabolic diseases, 515
in small intestine, in elderly persons, in amyloidosis, 599-600
312-313 liver, in hemochromatosis, 639, 641
Bacteriuria, in pregnancy, 25 in Wilson’s disease, 670
Barium studies, in amyloidosis, 600-601 small intestine, in celiac disease, 457-458
in gastroesophageal reflux disease, 737 in Whipple’s disease, 691
CUMULATIVE INDEX 1998 909
Bismuth subsalicylate, in diarrhea, in Calcium phosphate precipitates, in home
pregnancy, 207 parenteral nutrition, 493-495
Bitot’s spots, in liver disease, 705 Caloric requirements, in pancreatitis, 423
Bleeding. See Hemorrhage. in pregnancy, 90-91
Blue rubber bleb nevus syndrome, Campylobacter infections, reactive arthritis
bleeding in, 622-623 in, 537
Body composition, in nutritional Canada-Cronkhite syndrome, 627-628
assessment, 348, 363-365 Cancer, colon, in Muir-Torre syndrome,
Body weight, in inflammatory bowel 629-630
disease, 436 septic arthritis in, 543-544
in nutritional assessment, 348-349 dermatologic disorders in, 630-632
loss of, in mesenteric vasculopathy, 839 esophageal, in scleroderma, 569-571
Bone densitometry, 514-515 in dermatomyositis, 764
Bone disease (osteoporosis and in pregnancy, biliary tract, 19
osteomalacia), 513-523 colorectal. See Colorectal cancer.
after gastrectomy, 515-516 gastric, 187-188
after gastrointestinal bypass surgery, 516 liver, 24
diagnosis of, 514-515 ovarian, 8-9
in alcoholic liver disease, 516-517 liver, in hemochromatosis, 644
in celiac disease, 519 nutritional factors in, 325-346
in cirrhosis, 517 antioxidants, 410-413
in Crohn's disease, 519-520 colorectal, 332-336
in cystic fibrosis, 520-521 dietary collective effects, 337-338
in home parenteral nutrition, 495-496 esophageal, 327-329
in liver transplantation, 518-519 gastric, 329-331
in parenteral nutrition, 521 oral, 326-327
in primary biliary cirrhosis, 517-518 small intestinal, 331-332
in viral hepatitis, 517 supplementation clinical trials, 336-
treatment of, 521 337
types of, 514 occult, polyarthritis in, 554
Bowel retraining, in laxative dependence, risk of, in celiac disease, 457
901 short bowel syndrome in, 468
Brain-gut interactions, 895-896 Candidiasis, esophageal, in diabetes
Broad ligament, torsion of, in pregnancy, mellitus, 863
pain in, 8 in scleroderma, 571
Bronchoconstriction, in gastroesophageal from corticosteroids, 772
reflux disease, 723-733 Carbohydrates, absorption of, in elderly
Bronchospasm, as gastroesophageal reflux persons, 315-316
trigger, 727-728 in enteral formulas, 378-379
Budd-Chiari syndrome, in pregnancy, 23 in pancreatitis, 426-427
Burns, intestinal epithelial malabsorption of, in scleroderma, 580
hyperpermeability in, 299 metabolism of, in kidney failure, 878
Butyrate, as nutritional supplement, Carbuterol, in asthma, gastroesophageal
394-396 reflux from, 729
Bypass arthritis, 543 Carcinoembryonic antigen, in colorectal
cancer evaluation, in pregnancy, 234
Carcinoid syndrome, 632
Carcinoma, hepatocellular, in
Calcium, dietary, colorectal cancer and, hemochromatosis, 644
334-335 Cardiomyopathy, dilated, in
in elderly persons, 320-321 hemochromatosis, 645-646
malabsorption of, in celiac disease, Catalase, 405
456-457 Cataract, in Wilson’s disease, 705
requirements for, in pregnancy, 96-97 Cathartics, in constipation, in pregnancy,
intestinal epithelial hyperpermeability 204
and, 296 Catheter problems, in home parenteral
supplementary, in inflammatory bowel nutrition, 490-493, 497, 499-500
disease, 438 Celiac axis, anastomoses of, 788
in short bowel syndrome, 474 anatomy of, 786
910 CUMULATIVE INDEX 1998
Celiac disease, 453-465 in short bowel syndrome, 474
bone disease in, 519 Chondrodysplasia, metaphyseal, in
cancer risk in, 457 Shwachman’s syndrome, 552
clinical features of, 456-457 Chorea, in Wilson’s disease, 667
diagnostic criteria for, 457-458 Chromium, measurement of, in nutritional
epidemiology of, 456 assessment, 355
genetic factors in, 454 requirements for, in pregnancy, 99
in diabetes mellitus, 870 Chronic obstructive pulmonary disease,
in elderly persons, 313 gastroesophageal reflux disease in,
intestinal epithelial hyperpermeability 727-728
in, 298 Churg-Strauss syndrome, gastrointestinal
oats in, 459-460 manifestations of, 750-751
pathogenesis of, 453-455 Cimetidine, in gastroesophageal reflux
pathology of, 455-456 disease, in asthma, 731-732
refractory, 460-461 in pregnancy, 163
rheumatic disease in, 543 in peptic ulcer disease, in pregnancy, 181
serologic testing in, 458-459 in short bowel syndrome, 471
Celiotomy, for enteral nutrition, 377 Cirrhosis, biliary. See Primary biliary
Cerebellum, copper accumulation in, 667 cirrhosis.
Ceruloplasmin, in Wilson’s disease,
bone disease in, 517-518
deficiency of, 661-662, 669, 671
copper-associated, nonwilsonian (Indian
measurement of, 671
childhood), 672-673
Chaperones, copper, 655-659
in Wilson’s disease, 664-665
Chelation therapy, for hemochromatosis,
rheumatic disease in, 554
649
Cisapride, in gastroesophageal reflux
for Wilson’s disease, 673-674
disease, 740
Chemical hypoxia, intestinal epithelial
in pregnancy, 163
hyperpermeability in, 292-293
Chemotherapy, complications of, in scleroderma, 575-576
antioxidants in, 413 in gastroparesis, in diabetes mellitus,
for colorectal cancer, in pregnancy, 241- 866
244, 264 in nausea and vomiting of pregnancy,
Chewing difficulties, in giant cell arteritis, 142-143
768 Clonidine, in diarrhea, in diabetes
in rheumatoid arthritis, 757-758 mellitus, 870
Chlorpromazine, in nausea and vomiting Clostridium difficile infections, reactive
of pregnancy, 140-141 arthritis in, 537-538
Cholangiography, in pregnancy, 78-79 versus mesenteric vasculopathy, 832
Cholangitis, ascending, in diabetes Coagulopathy, in Wilson’s disease, 669
mellitus, 868 mesenteric vasculopathy in, 804, 829,
Cholecystectomy, in pregnancy, 59, 77-79 845-846
Cholecystitis, in pregnancy, 17-18 Codeine, in short bowel syndrome, 472
surgery for, 77-79 Cognitive-behavioral therapy, for
Choledocholithiasis, in pregnancy, 18 functional gastrointestinal disorders,
endoscopic retrograde 902
cholangiopancreatography, 49, Colchicine, in familial Mediterranean fever,
54-59, 78-79 609, 765
surgery for, 77-79 Colestipol, in cholestatic liver disease, 619
Cholelithiasis, in diabetes mellitus, 868 Colic, biliary, in pregnancy, 17-18
in pregnancy, 17-18 Colic arteries, anatomy of, 786
endoscopic retrograde cholangiopan- Colitic arthritis, 766-767
creatography, 49, 54-59 in inflammatory bowel disease, 540
surgery for, 77-79 Colitis, Crohn’s, versus mesenteric
in short bowel syndrome, 472 vasculopathy, 833
Cholestasis, dermatologic disorders in, in reactive arthritis, 766
618-620 in rheumatoid arthritis, 758
Cholesterol, serum, in nutritional ischemic, 828-835
assessment, 352 causes of, 828-829
Cholestyramine, in cholestatic liver chronic, 835-836
disease, 619 clinical features of, 830
CUMULATIVE INDEX 1998 911
diagnosis of, 830-832 outcome of, 244-245, 259, 263-264
differential diagnosis of, 832-833 pathology of, 232-234
epidemiology of, 829-830 staging of, 233
prognosis for, 835 treatment of, 239-244, 259-263
sites affected in, 829 nutritional factors in, 332-336
treatment of, 833-835 Computed tomography, in colorectal
rheumatic disease in, collagenous, 542 cancer, in pregnancy, 236
lymphocytic, 542 in mesenteric vasculopathy, 796, 806—
ulcerative. See Inflammatory bowel disease; 810, 832, 837, 840
Ulcerative colitis. in nutritional assessment, 365
Collagen, overproduction of, in Constipation, in diabetes mellitus, 870
scleroderma, 564-565 in pregnancy, complications of, 204-205
Collagenous colitis, rheumatic disease in, definition of, 197
542 epidemiology of, 197
Collateral circulation, of mesenteric evaluation of, 203
arteries, 788-789 gastrointestinal transit time and, 197
Colon, adynamic ileus of, in pregnancy, pathophysiology of, 197-203
physiologic versus abnormal, 197
14-15
amyloidosis of, 599 treatment of, 203-204
in scleroderma, 585-586
cancer of. See Colorectal cancer.
Contrast agents, for endoscopy, in
carcinoma of, in Muir-Torre syndrome,
pregnancy, 43, 49
629-630
Copper, accumulation of, antioxidants in,
septic arthritis in, 543-544
414
disorders of, versus mesenteric vasculo-
in Indian childhood cirrhosis, 672-673
pathy, 808
homeostasis of, normal, 655-657
hemorrhage in, in blue rubber bleb ne-
measurement of, in nutritional assess-
vus syndrome, 623
ment, 355
hyperpermeability of. See Intestinal epithe-
metabolism of, in Menkes’ disease, 658
lial hyperpermeability.
in Wilson’s disease, 658-661
interposition of, in short bowel syn-
requirements for, in pregnancy, 98-99
drome, 476 urinary, measurement of, in Wilson’s dis-
perforation of, in colorectal cancer, 228
ease, 671
petechiae of, in Henoch-Schénlein pur- Corneal disease, in inflammatory bowel
pura, 751 disease, 700
polyposis of, dermatologic disorders in, in liver disease, 704-705
626-630 Corticosteroids, gastrointestinal effects of,
ophthalmologic disorders in, 706-707 771-773
resection of, in mesenteric vasculopathy, in Behcet's disease, 704
834-835 in episcleritis, in inflammatory bowel
scleroderma of, 585-588 disease, 701
Colonoscopy, in mesenteric vasculopathy, in inflammatory bowel disease, in preg-
798, 808, 811, 831-832, 840 nancy, 218
in pregnancy, 60-62 in keratitis, in inflammatory bowel dis-
in colorectal cancer, 236-238 ease, 700
Colorectal cancer, antioxidants in, 411-413 in nausea and vomiting of pregnancy,
in pregnancy, 225-256, 257-267 143-144
anal, 264-265 in uveitis, in inflammatory bowel dis-
biology of, 231-232 ease, 700
clinical features of, 227-230 Cough, in gastroesophageal reflux disease,
delivery mode in, 262 733-734
diagnosis of, 258-259 Cowden’s disease, 628-629
delayed, 225-226 Creatinine-height index, in nutritional
differential diagnosis of, 230-231 assessment, 349-350
epidemiology of, 226-227 Critical illness, enteral nutrition in,
evaluation of, 234-238 373-374
fetal effects of, 259 Crohn’s colitis, versus mesenteric
histology of, 233-234 vasculopathy, 833
location of, 232-233, 257-258 Crohn’s disease. See also Inflammatory
metastasis from, 234, 262 bowel disease.
912 CUMULATIVE INDEX 1998
Crohn’s disease (Continued) in polyposis, 626-630
amyloidosis in, 606-608 Dermatomyositis, gastrointestinal
antioxidants in, 410 manifestations of, 762-764
bone disease in, 519-520 in viral hepatitis, 547
dermatologic disorders in, 632-633 Diabetes mellitus, 861-874
in elderly persons, 315 abdominal pain in, 871
in polymyositis, 763-764 anorectal abnormalities in, 871
in reactive arthritis, 765 biliary tract abnormalities in, 868
intestinal epithelial hyperpermeability constipation in, 870
in, 298-299 diarrhea in, 869-870
nutrition in. See Inflammatory bowel dis- esophageal abnormalities in, 862-863
ease, nutrition in. gastric abnormalities in, 863-867
in hemochromatosis, 646-647
ophthalmologic disorders in, 697-701
in pancreatitis, 428
rheumatic disease in, 539-542
in pregnancy, nutrition in, 113
short bowel syndrome in, 468
liver disease in, 868
Cryoglobulinemia, in viral hepatitis,
pancreatic disease in, 868-869
545-548, 616-617
small bowel dysfunction in, 867-868
Culdocentesis, in ectopic pregnancy, 5-6 Dialysis, amyloidosis in, 596, 603, 883,
Cullen’s sign, in pancreatitis, 633 886-887
Cultural factors, in functional gastrointestinal bleeding in, 882-883
gastrointestinal disorders, 897 nausea and vomiting in, 882
Cyclizine, in nausea and vomiting of pancreatitis in, 882
pregnancy, 141 peritonitis in, 880-882
Cyclophosphamide, gastrointestinal effects prevalence of, 875
of, 774-775 Diaphragmatic hernia, in pregnancy,
Cyclosporine, in inflammatory bowel 13-14, 81-82
disease, in pregnancy, 219 Diarrhea, in amyloidosis, 598
Cyst(s), choledochal, in pregnancy, 18-19 in Canada-Cronkhite syndrome, 627-628
Cysteine dioxygenase deficiency, in in celiac disease, 456
rheumatoid arthritis, 544 in diabetes mellitus, 869-870
Cystic fibrosis, bone disease in, 520-521 in enteral nutrition, 380
rheumatic disease in, 552-553 in mesenteric vasculopathy, 793, 805, 830
Cystitis, in pregnancy, 25 in pregnancy, definition of, 197-198
Cytokines, deficiency of, in Whipple’s differential diagnosis of, 205-206
disease, 685-686 epidemiology of, 205
intestinal epithelial hyperpermeability evaluation of, 206
from, 294-295 pathophysiology of, 206
Cytomegalovirus esophagitis, in physiologic versus abnormal, 197
scleroderma, 571 treatment of, 206-208
in rheumatoid arthritis, 758
in scleroderma, 580-581, 583, 588
in short bowel syndrome, 472-473
Decompression, gastrointestinal, in in tube feeding, 108
scleroderma, 583 in Whipple’s disease, 686
Defecography, in scleroderma, 576 Diatrizoate, in endoscopy, in pregnancy,
Deferiprone, in hemochromatosis, 649 43, 49
Diazepam, in endoscopy, in pregnancy,
Deferoxamine, in hemochromatosis, 649
40-42
Degos’ disease, 625
Diet, in gastroesophageal reflux disease,
Dehydration, in hyperemesis gravidarum,
739
136
in hemochromatosis, 650
Delayed cutaneous hypersensitivity test, in in peptic ulcer disease, in pregnancy,
nutritional assessment, 351 177-179
Densitometry, in bone disease, 514-515 Dimenhydrinate, in nausea and vomiting
Dermatologic disorders, 615-636 of pregnancy, 141-142
in cancer, 630-632 Dimercaprol, in Wilson’s disease, 673
in hemorrhage, 621-625 Dimethyl sulfoxide, in ulcer disease, 409
in inflammatory bowel disease, 632-633 1,2-Dimethyl-3-hydroxypyrid—4-one
in liver disease, 615-621 (deferiprone), in hemochromatosis,
in pancreatic disease, 633-634 649-650
CUMULATIVE INDEX 1998 913
Diphenhydramine, in nausea and vomiting in Sjégren’s syndrome, 760
of pregnancy, 141-143 Dystonia, in Wilson’s disease, 667
Discriminant analysis, in nutritional
assessment, 352
Diverticula, in scleroderma, colonic, 585
small intestinal, 581 Eclampsia, abdominal pain in, 19-21
Diverticulitis, versus mesenteric Ectopic pregnancy, pain in, 2-7
vasculopathy, 806, 833 abdominal, 6
Domperidone, in gastroparesis, in diabetes intrauterine pregnancy with, 7
mellitus, 866 Ehlers-Danlos syndrome, 624-625
Doppler ultrasonography, in mesenteric Elderly persons, nutrition in, 309-324
vasculopathy, 840-841 home parenteral, 487
Double halo sign, in computed macronutrient handling in, 315-317
tomography, in mesenteric micronutrient handling in, 317-321
vasculopathy, 832 pancreas changes in, 315
Double-decidual sac sign, in ectopic small intestine changes in, 312-315
pregnancy, 5 stomach changes in, 310-312
Droperidol, in nausea and vomiting of Electrolyte imbalance, in home parenteral
pregnancy, 143 nutrition, 498
Drugs, in pregnancy, abdominal pain in hyperemesis gravidarum, 136
from, 27 Elemental diets, in scleroderma, 584
colorectal cancer chemotherapy, Embolism, air, in home parenteral
241-244 nutrition, 499
in endoscopy, 38-49 of mesenteric arteries, 789-790, 798, 800-
after procedures, 46-48 801, 829
antibiotics, 45-46 Endarterectomy, in mesenteric
before procedures, 39-44 vasculopathy, 844
colonic preparations, 48-49 Endometriosis, in pregnancy, pain in, 9
during procedures, 44-45 Endomysial antibodies, in celiac disease,
in inflammatory bowel disease, 458
217-220 Endoscopic retrograde
in nausea and vomiting, 140-144 cholangiopancreatography, in
in peptic ulcer disease, 179-184 pregnancy, 49, 54-59, 78-79
nutritional effects of, 105 Endoscopy. See also Colonoscopy;
teratogenic period of, 139
Esophagogastroduodenoscopy.
in vasculitis, gastrointestinal manifesta-
in amyloidosis, 601
tions of, 769-775 :
in pregnancy, 37-71
intestinal epithelial hyperpermeability
colonoscopy, 60-62, 236-238
from, 292-293
esophagogastroduodenoscopy, 50-54,
mesenteric vasculopathy from, 846
159-160, 175-177, 185
Drummond, marginal artery of, anatomy
gastrostomy, 59
of, 788
in gastrointestinal bleeding, 49-50
Dry eye and mouth, in primary biliary
indications for, 37
cirrhosis, 706
medications in, 38-49
in Sjégren’s syndrome, 759-760
after procedures, 43, 46-48
in viral hepatitis, 547
Dual-energy x-ray absorptiometry, in antibiotics, 42-43, 45-46
nutritional assessment, 364 before procedures, 39-42
Dukes classification, of colorectal cancer, colonic preparations, 48-49
233 during procedures, 42, 44-45
Duodenitis, in kidney failure, 884-885 retrograde cholangiopancreatography,
Duodenum, ulcers of. See Peptic ulcer 49, 54-59, 78-79
disease. sigmoidoscopy, 59-62, 237
Dyspepsia. See also Gastroesophageal reflux in scleroderma, 573-574
disease; Peptic ulcer disease. Endotoxemia, intestinal epithelial
in pregnancy, differential diagnosis of, hyperpermeability in, 295-296
173-174 Energy costs, of pregnancy, 90-91
Dysphagia, in amyloidosis, 597 Enprostil, in peptic ulcer disease, in
in gastroesophageal reflux disease, in pregnancy, 183-184
pregnancy, 155 Enteral nutrition, 371-386
914 CUMULATIVE INDEX 1998
Enteral nutrition (Continued) in kidney failure, 883
access for, 377-378 pill-induced, in scleroderma, 570
complications of, 379-381 reflux. See Gastroesophageal reflux disease.
delivery methods for, 378 Esophagogastroduodenoscopy, in diabetes
formulas for, 378-379 mellitus, 864
disease-specific, 381-382 in mesenteric vasculopathy, 798, 811, 840
immune-enhancing, 376 in pregnancy, 159-160
in pancreatitis, 426-427 in nausea and vomiting, 50-54
gut barrier and, 371-372 in peptic ulcer disease, 175-177, 185
in critical illness, 373-374 Esophagography, in scleroderma, 571
in inflammatory bowel disease, 374~375, Esophagoscopy, in amyloidosis, 601
439-441, 443-444 in scleroderma, 573-574
in pancreatitis, 424-426, 430-431 Esophagus, acid reflux into. See
in pregnancy, complications of, 108 Gastroesophageal reflux disease.
formulas for, 108-109 amyloidosis of, 597
in hyperemesis gravidarum, 111-112 Barrett’s, in scleroderma, 569-571, 573-
versus parenteral nutrition, 107 574
in short bowel syndrome, 474 nutritional factors in, 328-329
indications for, 372-373 cancer of, antioxidants and, 412
mucosal immunity and, 372
nutritional factors in, 327-329
nutrient pharmacotherapy in. See Phar-
disorders of, in Behcet’s disease, 753
macotherapy, nutrient.
gastric content reflux into. See Gastro-
timing of, 376-377
esophageal reflux disease.
versus parenteral nutrition, 373
motility disorders of, asthma in, 723-724
in critical illness, 374
in diabetes mellitus, 862-863
in inflammatory bowel disease, 375
in kidney failure, 883-884
in pancreatitis, 424-426, 430-431
in polymyositis, 762-763
Enteritis, lupus, 753-754
in pregnancy, 126-128, 158-159
Enteropathy, gluten (protein-losing). See
Celiac disease. in rheumatoid arthritis, 758-759
Enteropathy-associated T-cell lymphoma, in Sjégren’s syndrome, 760
in celiac disease, 457 in systemic lupus erythematosus, 755-
Enteroscopy, in amyloidosis, 601 756
in mesenteric vasculopathy, 798, 811 scleroderma of, 567-577
Enzymes, pancreatic, in steatorrhea, gastroesophageal reflux in, 568-570
428-429 complications of, 569-570
Eosinophilic infiltration, in Churg-Strauss diagnosis of, 571-574
syndrome, 750 treatment of, 575-577
Epidermal growth factor, as nutritional infectious esophagitis in, 571
supplement, 393-394 lower sphincter dysfunction in, 565-
Episcleritis, in inflammatory bowel 577
disease, 701 pill-induced esophagitis in, 570
Episiotomy, in inflammatory bowel scleroderma bark in, 571
disease, 217 variceal bleeding in, in mesenteric vascu-
Epithelia, intestinal, hyperpermeability of. lopathy, 837
See Intestinal epithelial hyperpermeability. Estrogens, in pregnancy, constipation and,
ERCP (endoscopic retrograde 199-202
cholangiopancreatography), in gastroesophageal reflux and, 157-158
pregnancy, 49, 54-59, 78-79 nausea and vomiting and, 126
Ergometry, in nutritional assessment, 362 Exercise, caloric requirements for, in
Erythema, in glucagonoma syndrome, 632 pregnancy, 104
in liver disease, 620-621 in colorectal cancer prevention, 335-336
Erythema nodosum, in inflammatory tolerance of, in nutritional assessment,
bowel disease, 633 362
Erythromycin, in gastroesophageal reflux, Eye disorders. See Ophthalmologic disorders.
in scleroderma, 576
in gastroparesis, in diabetes mellitus,
866
Esophagitis, candidal, in diabetes mellitus, Fallopian tube disorders, in pregnancy,
863 pain in, 8-9